Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.
about
Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-AnalysisCurrent and future antiviral drug therapies of hepatitis B chronic infectionSuppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysisComparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B.Update on tenofovir toxicity in the kidney.Treatment of children with chronic viral hepatitis: what is available and what is in store.Current developments in nucleoside/nucleotide analogues for hepatitis B.Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B.
P2860
Q26765932-D9C1EBFC-DE59-4F3E-ABF5-0F819C768874Q28084820-DA027C9E-DA51-4B5C-9383-B5B5BEEBC249Q34847029-D5E2D1AF-D045-476F-BF21-D8595616AEE0Q35844432-5A56F4DE-4706-4C89-88BA-58E224163837Q38033446-FECF457F-044B-492D-B656-5E1C8CADF6A5Q38127616-FB611E80-A3C7-4DCA-B8D1-7876AFDB776CQ38208628-1389BB46-EC5D-46D0-8B44-110B2A3A2AE8Q39277056-D9704C07-8944-43F9-ACD8-3D9A18A196BEQ41224775-39134E57-D773-49B5-8115-91EE671A193C
P2860
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy and tolerance of a co ...... a European multicenter study.
@en
Efficacy and tolerance of a co ...... a European multicenter study.
@nl
type
label
Efficacy and tolerance of a co ...... a European multicenter study.
@en
Efficacy and tolerance of a co ...... a European multicenter study.
@nl
prefLabel
Efficacy and tolerance of a co ...... a European multicenter study.
@en
Efficacy and tolerance of a co ...... a European multicenter study.
@nl
P2093
P50
P1433
P1476
Efficacy and tolerance of a co ...... : a European multicenter study
@en
P2093
Claire Cruiziat
François Bailly
Harry L Janssen
Heiner Wedemeyer
Jérôme Dumortier
Katja Deterding
Maria Buti
Pierre Pradat
Roeland Zoutendijk
Si-Nafa Si-Ahmed
P356
10.1016/J.ANTIVIRAL.2011.07.003
P577
2011-07-13T00:00:00Z